Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MIF | P14174 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL181910 | 0.92 | MMP1 (0.45) | ALDH1A1TDP1MMP1MMP2MMP3 | |
| SCHEMBL8366458 | 0.92 | ALDH1A1 (0.48) | ALDH1A1TDP1MMP1MMP2MMP3 | |
| SCHEMBL15772877 | 0.87 | MMP1 (0.42) | ALDH1A1TDP1MMP1MMP2MMP3 | |
| SCHEMBL18127624 | 0.87 | ALDH1A1 (0.44) | ALDH1A1TDP1MMP1MMP2MMP3 | |
| SCHEMBL8339335 | 0.86 | ALDH1A1 (0.50) | ALDH1A1TDP1MMP1MMP2MMP3 | |
| SCHEMBL30829392 | 0.86 | MMP1 (0.50) | ALDH1A1TDP1MMP1MMP2MMP3 | |
| SCHEMBL386476 | 0.85 | ALDH1A1 (0.68) | ALDH1A1TDP1MMP1MMP2MMP3 | |
| SCHEMBL28583742 | 0.85 | CA1 (0.44) | ALDH1A1TDP1MMP1MMP2MMP3 | |
| SCHEMBL18127622 | 0.85 | LMNA (0.45) | ALDH1A1TDP1MMP1MMP2MMP3 | |
| SCHEMBL181917 | 0.84 | MMP1 (0.43) | ALDH1A1TDP1MMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431466-A | Environment-friendly synthesis method of cordycepin by taking inosine as raw material | 深圳市倍昂生物科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| US-12215074-B2 | Process for the production of peroxyesters | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2025-02-04 | — | — | US | claimed |
| US-12209065-B2 | Process for the production of diacyl peroxides | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2025-01-28 | — | — | US | claimed |
| CN-119191789-A | Gangue-based lightweight concrete material, and preparation method and application thereof | 山东交通学院 | 2024-12-27 | — | — | CN | claimed |
| CN-114031639-B | Preparation method of biphospide with P-O-C-P structure | 烟台大学 | 2024-07-12 | — | — | CN | claimed |
| US-11976035-B2 | Process for the production of diacyl peroxides | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-05-07 | — | — | US | claimed |
| US-11976034-B2 | Process for the production of diacyl peroxides | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-05-07 | — | — | US | claimed |
| CN-117865908-A | Synthesis method of 2- (1-hydroxyethyl) thiazole-4-carboxylic acid intermediate | 合肥欧创基因生物科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| US-20230357257-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF NOROXYMORPHONE FROM MORPHINE | NAVIN SAXENA RESEARCH & TECHNOLOGY PVT. LTD. (IN) | 2023-11-09 | — | — | US | claimed |
| EP-4267583-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF NOROXYMORPHONE FROM MORPHINE | Navin Saxena Research & Technology Pvt. Ltd. (IN) | 2023-11-01 | — | — | EP | claimed |
| WO-2007098612-A1 | GASTRIC ACID RESISTANT GELATIN CAPSULE COMPOSITION AND METHOD FOR PRODUCING SAME | LABORATOIRES MAUVES INC. (CA) | 2007-09-07 | — | — | WO | claimed |
| WO-2007020432-A2 | HIGH STRENGTH DEVICES AND COMPOSITES | SMITH & NEPHEW, PLC (GB) | 2007-02-22 | — | — | WO | claimed |
| CN-1594271-A | Method for preparing ester by high sterically hindered alcohol | SHENZHEN GUANLIDA BOTON FLAVOU (CN) | 2005-03-16 | — | — | CN | claimed |
| US-20040242722-A1 | Biodegradable polymer systems | SMITH & NEPHEW PLC (GB) | 2004-12-02 | — | — | US | claimed |
| EP-1401510-A1 | BIODEGRADABLE POLYMER SYSTEMS | Smith & Nephew PLC (GB) | 2004-03-31 | — | — | EP | claimed |
| WO-2003004071-A1 | BIODEGRADABLE POLYMER SYSTEMS | SMITH & NEPHEW PLC (GB) | 2003-01-16 | — | — | WO | claimed |
| US-5922633-A | THERMAL LATENT ACID CATALYST CONSISTS OF AN EPOXY COMPOUND, A SULFUR COMPOUND AND LEWIS ACID | NOF CORPORATION (JP) | 1999-07-13 | — | — | US | claimed |
| EP-0399839-A2 | Intraocular pressure reducing 15-acyl prostaglandins | ALLERGAN, INC (US) | 1990-11-28 | — | — | EP | claimed |
| EP-0239194-A2 | Methods for preparing hydroxy compounds and intermediates | SYMBICOM AB (SE) | 1987-09-30 | — | — | EP | claimed |
| US-4163753-A | FROM AN ALIPHATIC ACID ANHYDRIDE AND A TRICHLOROMETHYL AROMATIC COMPOUND | Diaz Chemical Corporation (US) | 1979-08-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357257-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF NOROXYMORPHONE FROM MORPHINE | OPRM1, OPRK1, OPRD1 | ALDH1A1 376/4885TDP1 3867/4885MMP1 4494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.